Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt-0

Abstract

<p><b>Copyright information:</b></p><p>Taken from "Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt"</p><p>Journal of Neuroinflammation 2008;5():4-4.</p><p>Published online 18 Jan 2008</p><p>PMCID:PMC2254610.</p><p></p>ignificantly induced NO generation, and pretreatment with pioglitazone inhibited this LPS-induced NO production in a dose-dependent manner. Data presented are representative of three independent experiments (n = 3). (***< 0.001 vs. control ###< 0.001 vs. LPS